Takeda notifies 4.48 shareholding in TiGenix
REGULATED INFORMATIONPRESS RELEASE Takeda notifies 4.48 shareholding in TiGenix Leuven Belgium January 9 2017 700h CET TiGenix NV Euronext Brussels and Nasdaq TIG; "TiGenix" publishes...
View ArticleSigmoid Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySigmoid Pharma Ltd Sigmoid formerly Sigmoid Biotechnologies Ltd is a pharma company that develops therapies for unmet clinical needs in gastrointestinal and immunological diseases and disorders....
View ArticleRedHill Biopharma Announces Exercise of Stock Options by Directors and Senior...
Members of RedHill's Board of Directors senior management and Advisory Board have exercised stock options to purchase an aggregate of 1700000 ordinary shares equivalent to 170000 American...
View ArticleAllergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain...
DUBLIN and INDIANAPOLIS Jan. 9 2017 PRNewswire Allergan plc NYSE AGN and Assembly Biosciences Inc. NASDAQ ASMB today announced that Allergan has entered into a research development collaboration and...
View ArticleAllergan Broadening GI Pipeline Expanding Into Parkinson's
Allergan today disclosed deals that will expand its gastrointestinal pipeline with four potential treatments focused on the microbiome as well as broaden its R&D portfolio through an option to...
View ArticleCrohn's disease risk and prognosis determined by different genes study finds
Researchers have identified a series of genetic variants that affect the severity of Crohn's disease an inflammatory bowel disease but surprisingly none of these variants appear to be related to an...
View ArticleECRI Institute Preps Hospital Leaders on Top 10 Technology Issues to Watch in...
PLYMOUTH MEETING Pa. Jan. 9 2017 PRNewswireUSNewswire The new and emerging healthcare innovations of 2017 come with a lot of promises. And just like every other year hospital leaders must remain...
View ArticleCrohn's disease risk and prognosis determined by different genes
Researchers have identified a series of genetic variants that affect the severity of Crohn's disease an inflammatory bowel disease but surprisingly none of these variants appear to be related to an...
View ArticleAllergan in deals with Lysosomal Therapeutics Assembly
Allergan plc NYSEAGN announced two deals Monday gaining an exclusive option to acquire neurodegenerative disease company Lysosomal Therapeutics Inc. Cambridge Mass. and a license for rights to four...
View ArticleImmune Pharmaceuticals Will Request an Appeal to Regain Compliance with...
NEW YORK Jan. 9 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP "Immune" announced today that it intends to request a hearing before the Nasdaq Listing Qualifications Staff Panel to appeal a...
View ArticleSpecial Diet May Be Boon for Kids With Crohn's Colitis
MONDAY Jan. 9 2017 Children with Crohn's disease and ulcerative colitis may be able to achieve relief without medications by eating a special diet a small study suggests.The diet includes nonprocessed...
View ArticleTiGenix NV TIG Medical Equipment Deals and Alliances Profile Prices from USD...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleExploring the genetic architecture of inflammatory bowel disease by...
Carl Anderson Jeffrey Barrett and colleagues use wholegenome sequencing and imputation to explore the genetic architecture of inflammatory bowel disease. They identify a lowfrequency missense variant...
View ArticleGenomewide association study identifies distinct genetic contributions to...
James Lee Kenneth Smith and colleagues report a withincases genomewide association analysis for Crohn's disease to identify genetic loci specifically associated with disease severity and outcome. They...
View ArticleDiplomat Pharmacy Inc DPLO Pharmaceuticals Healthcare Deals and Alliances...
SummaryDiplomat Pharmacy Inc Diplomat Pharmacy is a healthcare company that provides medication management and clinical services. The pharmacy offers personalized medication therapies to people with...
View ArticleNatco Pharma Ltd NATCOPHARM Pharmaceuticals Healthcare Deals and Alliances...
SummaryNatco Pharma Ltd Natco Pharma focuses on the research development manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage...
View ArticleInfusion Express Opens in Fremont California
FREMONT Calif. Jan. 10 2017 PRNewswire Infusion Express a patientfocused alternative to hospital infusion centers today announced its second San Francisco Bay Area treatment center as part of a...
View ArticleEnzon Pharmaceuticals Inc ENZN Pharmaceuticals Healthcare Deals and Alliances...
SummaryEnzon Pharmaceuticals Inc Enzon is a biotechnology company which researches and develops therapeutics for patients with high unmet medical needs. The company's royalty products include PegIntron...
View ArticleResponsive Health Flagship Product Prescription Universe featured on...
Journalists David Brancaccio and Dan Gorenstein report apps can be the difference between another hospitalization and tweaking meds.New York NY PRWEB January 11 2017 Responsive Health a spinoff from...
View Article